Pain Medicine 2021 Jan 29;pnaa443. doi: 10.1093/pm/pnaa443. Online ahead of print Serge Perrot, Gisèle Pickering, Michel Lantéri-Minet, Nadine Attal Objective: Peripheral neuropathic pain (PNP) represents a major public health issue. Severe or refractory cases warrant tertiary multidisciplinary management, but little information is
Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society
Cephalalgia 2021 Jan 20;333102421989247 doi: 10.1177/0333102421989247. Online ahead of print. Hans Christoph Diener , Messoud Ashina, Isabelle Durand-Zaleski, Tobias Kurth, Michel Lantéri-Minet, Richard B Lipton, Daniel A Ollendorf, Patricia Pozo-Rosich, Cristina Tassorelli, Gisela Terwindt Abstract The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology
Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2-4 preventives were not useful: results from the LIBERTY study
Journal of neurology, neurosurgery, and psychiatry 2021 Jan 5;jnnp-2020-324396 doi: 10.1136/jnnp-2020-324396. Online ahead of print. Michel Lanteri-Minet, Peter J Goadsby, Uwe Reuter, Shihua Wen, Peggy Hours-Zesiger, Michel D Ferrari, Jan Klatt Objective: To evaluate the effect of erenumab on patient-reported, functional outcomes in patients with episodic